The beneficial effects α-cyclodextrin on blood lipids and weight loss in healthy humans

Obesity

Volumn 19, Issue 6, 2011, Pages 1200-1204

  Comerford, Kevin B ^a   Artiss, Joseph D ^b,c   Jen, K L Catherine ^c,d   Karakas, Sidika E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ArtJen Complexus Holdings Corp   (Canada)

^d WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CYCLODEXTRIN; APOLIPOPROTEIN B; GLUCOSE; INSULIN; LEPTIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LEPTIN BLOOD LEVEL; LIPID BLOOD LEVEL; MALE; OBESITY; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TREATMENT DURATION; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; ALPHA-CYCLODEXTRINS; ANTICHOLESTEREMIC AGENTS; APOLIPOPROTEINS B; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DIETARY FIBER; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OVERWEIGHT; PATIENT DROPOUTS; SOLUBILITY; WEIGHT LOSS; YOUNG ADULT;

MUS; ZEA MAYS;

EID: 79957449611     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.280     Document Type: Article

References (12)

1. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010;303:235-241.
2. Aarsland A, Chinkes D, Wolfe RR. Hepatic and whole-body fat synthesis in humans during carbohydrate overfeeding. Am J Clin Nutr 1997;65: 1774-1782. (Pubitemid 27240693)
3. Artiss JD, Brogan K, Brucal M, Moghaddam M, Jen KL. The effects of a new soluble dietary fiber on weight gain and selected blood parameters in rats. Metabolism 2006;55:195-202. (Pubitemid 43098987)
4. Grunberger G, Jen KL, Artiss JD. The benefits of early intervention in obese diabetic patients with FBCx: a new dietary fibre. Diabetes Metab Res Rev 2007;23:56-62. (Pubitemid 46152487)
5. Gallaher D, Gallaher C, Plank D. Alpha-cyclodextrin selectively increases fecal excretion of saturated fats. FASEB J 2007;21:A730.
6. Sjöström L, Rissanen A, Andersen T et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet 1998;352: 167-172. (Pubitemid 28327800)
7. Buckley JD, Thorp AA, Murphy KJ, Howe PR. Dose-dependent inhibition of the post-prandial glycaemic response to a standard carbohydrate meal following incorporation of 1-cyclodextrin. Ann Nutr Metab 2006;50: 108-114. (Pubitemid 43325905)
8. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Prately R et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with isnulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-1935. (Pubitemid 32472900)
9. Ishibashi S, Brown MS, Goldstein JL et al. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirusmediated gene delivery. J Clin Invest 1993;92:883-893. (Pubitemid 23262411)
10. Wagner EM, Jen KL, Artiss JD, Remaley AT. Dietary 1-cyclodextrin lowers low-density lipoprotein cholesterol and alters plasma fatty acid profile in low-density lipoprotein receptor knockout mice on a high-fat diet. Metab 2008;57:1046-1051. (Pubitemid 351978062)
11. Ziemke F, Mantzoros CS. Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr 2010;91:258S-261S.
12. Coppola A, Marfella R, Coppola L et al. Effect of weight loss on coronary circulation and adiponectin levels in obese women. Int J Cardiol 2009;134:414-416.